{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:53:55Z","timestamp":1790056435326,"version":"4.0.1"},"reference-count":83,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:00:00Z","timestamp":1548201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:p>CAR\u2010T cells have made dramatic inroads in targeting CD19\u2010positive B\u2010cell malignancies. This review focuses on application of CAR\u2010T cells in hematologic malignancies beyond targeting CD19, with specific attention to Hodgkin's lymphoma and acute myeloid leukemia.<\/jats:p>","DOI":"10.1002\/ajh.25398","type":"journal-article","created":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T10:39:23Z","timestamp":1547203163000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["CAR\u2010T cells beyond CD19, UnCAR\u2010Ted territory"],"prefix":"10.1002","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3111-0221","authenticated-orcid":false,"given":"Mark B.","family":"Leick","sequence":"first","affiliation":[{"name":"Cellular Immunotherapy Program Cancer Center, Massachusetts General Hospital  Boston Massachusetts"},{"name":"Harvard Medical School  Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela V.","family":"Maus","sequence":"additional","affiliation":[{"name":"Cellular Immunotherapy Program Cancer Center, Massachusetts General Hospital  Boston Massachusetts"},{"name":"Harvard Medical School  Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,1,23]]},"reference":[{"key":"e_1_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0146-z"},{"key":"e_1_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-1020"},{"key":"e_1_2_3_4_1","unstructured":"HornerMJRL KrapchoM NeymanN AminouR HowladerN AltekruseSF FeuerEJ HuangL MariottoA MillerBA LewisDR EisnerMP StinchcombDG EdwardsBK eds.SEER Cancer Statistics Review 1975\u20102006. 2009;https:\/\/seer.cancer.gov\/csr\/1975_2006\/."},{"key":"e_1_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2011.559668"},{"key":"e_1_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1706169"},{"key":"e_1_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4441"},{"key":"e_1_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1610497"},{"key":"e_1_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-09-457531"},{"key":"e_1_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0010-1"},{"key":"e_1_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0850"},{"key":"e_1_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2015.11.003"},{"key":"e_1_2_3_13_1","doi-asserted-by":"crossref","unstructured":"Pei\u2010HsuanChen KyleWright PhilippeArmand Caron A.Jacobson Zachary J.Roberts John M.Rossi AdrianBot William Y.Go Scott JRodig.Analysis of CAR\u2010T and immune cells within the tumor micro\u2010environment of diffuse large B\u2010cell lymphoma post CAR\u2010T treatment by multiplex immunofluorescence. In: American Society of Hematology Annual Meeting; 2018; San Diego CA.","DOI":"10.1182\/blood-2018-99-113644"},{"key":"e_1_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0178-z"},{"key":"e_1_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-04-842708"},{"key":"e_1_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.36"},{"key":"e_1_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.51.5.364"},{"key":"e_1_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2017.126"},{"key":"e_1_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-017-0246-1"},{"key":"e_1_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1525-0016(16)33558-4"},{"key":"e_1_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30436-1"},{"key":"e_1_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-14-0163"},{"key":"e_1_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1326437"},{"issue":"1","key":"e_1_2_3_24_1","first-page":"4450","article-title":"ROR1\u2010directed chimeric antigen receptor T cell recognition of self\u2010antigen is associated with acute toxicity, T cell dysfunction, and poor tumor control","volume":"130","author":"Rottman JB","year":"2017","journal-title":"Blood"},{"key":"e_1_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI86000"},{"key":"e_1_2_3_26_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.12079"},{"key":"e_1_2_3_27_1","doi-asserted-by":"publisher","DOI":"10.1309\/617DWB5GNFWXHW4L"},{"key":"e_1_2_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocit.2014.11.001"},{"key":"e_1_2_3_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-017-3029-3"},{"key":"e_1_2_3_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-04-711903"},{"issue":"22","key":"e_1_2_3_31_1","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1182\/blood.V128.22.1147.1147","article-title":"B\u2010cell maturation antigen (BCMA)\u2010specific chimeric antigen receptor T cells (CART\u2010BCMA) for multiple myeloma (MM): initial safety and efficacy from a phase I study","volume":"128","author":"Cohen AD","year":"2016","journal-title":"Blood"},{"key":"e_1_2_3_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.35.15_suppl.3010"},{"key":"e_1_2_3_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.35.15_suppl.LBA3001"},{"issue":"22","key":"e_1_2_3_34_1","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood.V128.22.812.812","article-title":"Lenalidomide enhances the function of CS1 chimeric antigen receptor redirected\u2010T cells against multiple myeloma","volume":"128","author":"Wang X","year":"2016","journal-title":"Blood"},{"key":"e_1_2_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(00)00093-X"},{"key":"e_1_2_3_36_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.137620"},{"key":"e_1_2_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.04.024"},{"key":"e_1_2_3_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4431"},{"key":"e_1_2_3_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/299065a0"},{"key":"e_1_2_3_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07740.x"},{"key":"e_1_2_3_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002965"},{"issue":"6","key":"e_1_2_3_42_1","first-page":"1116","article-title":"An anti\u2010CD30 chimeric receptor that mediates CD3\u2010\u03b6\u2010independent T\u2010cell activation against Hodgkin's lymphoma cells in the presence of soluble CD30","volume":"58","author":"Hombach A","year":"1998","journal-title":"Cancer Res"},{"key":"e_1_2_3_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-11-059139"},{"key":"e_1_2_3_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301467"},{"key":"e_1_2_3_45_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.151.5.2380"},{"key":"e_1_2_3_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1525-0016(16)34024-2"},{"key":"e_1_2_3_47_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI94306"},{"key":"e_1_2_3_48_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-1365"},{"key":"e_1_2_3_49_1","article-title":"Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions","volume":"7","author":"Weyden CA","year":"2017","journal-title":"Blood Cancer J"},{"key":"e_1_2_3_50_1","doi-asserted-by":"publisher","DOI":"10.1177\/2040620718774268"},{"key":"e_1_2_3_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.09.004"},{"key":"e_1_2_3_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0075-3"},{"key":"e_1_2_3_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402803"},{"key":"e_1_2_3_54_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-466706"},{"key":"e_1_2_3_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70281-5"},{"key":"e_1_2_3_56_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.13.3244"},{"key":"e_1_2_3_57_1","doi-asserted-by":"publisher","DOI":"10.1309\/E36008Y2H08Q1AYY"},{"key":"e_1_2_3_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2011.01.025"},{"key":"e_1_2_3_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2014.164"},{"key":"e_1_2_3_60_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-092817"},{"key":"e_1_2_3_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0201-9"},{"key":"e_1_2_3_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.05.013"},{"key":"e_1_2_3_63_1","doi-asserted-by":"publisher","DOI":"10.1186\/2050-7771-2-4"},{"issue":"12","key":"e_1_2_3_64_1","first-page":"1261","article-title":"Interleukin\u20103 receptor alpha chain (CD123) is widely expressed in hematologic malignancies","volume":"86","author":"Munoz L","year":"2001","journal-title":"Haematologica"},{"key":"e_1_2_3_65_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-03-1072"},{"key":"e_1_2_3_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2009.04.018"},{"key":"e_1_2_3_67_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-12-474056"},{"key":"e_1_2_3_68_1","doi-asserted-by":"crossref","unstructured":"TasianSK KenderianSS ShenF et al.Optimized depletion of chimeric antigen receptor T\u2010cells in murine xenograft models of human acute myeloid leukemia.Blood.2017.","DOI":"10.1182\/blood-2016-08-736041"},{"key":"e_1_2_3_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.62"},{"key":"e_1_2_3_70_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-09-529537"},{"issue":"22","key":"e_1_2_3_71_1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1182\/blood.V128.22.765.765","article-title":"Allogeneic Tcr\u03b1\/\u03b2 deficient CAR T\u2010cells targeting CD123 prolong overall survival of AML patient\u2010derived xenografts","volume":"128","author":"Guzman ML","year":"2016","journal-title":"Blood"},{"key":"e_1_2_3_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.04.017"},{"key":"e_1_2_3_73_1","unstructured":"Cellectis.Cellectis Reports Clinical Hold of UCART123 Studies.2017;http:\/\/www.cellectis.com\/en\/press\/cellectis-reports-clinical-hold-of-ucart123-studies\/#_ftn1 2018."},{"issue":"1","key":"e_1_2_3_74_1","first-page":"1359","article-title":"Treating relapsed\/refractory (RR) AML with biodegradable anti\u2010CD123 CAR modified T cells","volume":"130","author":"Cummins KD","year":"2017","journal-title":"Blood"},{"key":"e_1_2_3_75_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V130.Suppl_1.811.811"},{"key":"e_1_2_3_76_1","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2010.21"},{"key":"e_1_2_3_77_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2013.154"},{"issue":"2","key":"e_1_2_3_78_1","article-title":"Potential efficacy of human IL\u20101RAP specific CAR\u2010T cell in eliminating leukemic stem cells of chronic myeloid leukemia","volume":"5","author":"Kai Zhao SY","year":"2017","journal-title":"J Leuk"},{"key":"e_1_2_3_79_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0278-6"},{"key":"e_1_2_3_80_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-062315-120245"},{"key":"e_1_2_3_81_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0042-2"},{"key":"e_1_2_3_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12978"},{"key":"e_1_2_3_83_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00354"},{"key":"e_1_2_3_84_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.4052.4052"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.25398","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.25398","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ajh.25398","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.25398","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T20:39:48Z","timestamp":1694378388000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.25398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,23]]},"references-count":83,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.1002\/ajh.25398"],"URL":"https:\/\/doi.org\/10.1002\/ajh.25398","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,23]]},"assertion":[{"value":"2018-11-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}